Med. praxi. 2013;10(1):28-32 [Prakt. lékáren. 2012; 8(2): 66-69]

Erectile dysfunction, cardiovascular risk and current treatment options

MUDr.Ta»ána ©rámková, CSc.
Urologická klinika 1. LF UK a VFN Praha
Klinika traumatologie MU, Úrazová nemocnice Brno

Czech men (aprox. 54 %) suffer from erectile dysfunction (ED). Erectile dysfunction is defined as an inability to achieve and maintain

an erection sufficient for satisfactory sexual intercourse. Erectile dysfunction is the first symptom of seriouse diseases, especially

cardio vascular ones. Modern oral therapy by PDE 5 inhibitors is safe, effective and well tolerated. The second line therapy is based on

intracavernous injections of prostaglandin E 1. ED therapy leeds to achievement partner’s satisfaction and quality of life of inable man.

Keywords: erectile dysfunction, cardiovascular morbidity, PD E5 inhibitors, intracavernous therapy

Published: January 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©rámková T. Erectile dysfunction, cardiovascular risk and current treatment options. Med. praxi. 2013;10(1):28-32.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Weiss P, Zvěřina J. Sexuální chování obyvatelstva ČR IV. DEMA, Praha 2009.
    2. Zámečník L, a kol. Praktická andrologie dospělých. Praha, Mladá fronta 2010: 254.
    3. Breza J. Erektilné poruchy. 1. vyd., Osveta 1994: 270.
    4. Meluzín J. Erektilní dysfunkce a srdce. In: Pacik D. Erektilní dysfunkce pod lupou. 1. vyd. Adéla 2005: 9-16.
    5. Jackson G, Boon N, Eardely I, et al. Eectile dysfunction and coronory artery disease prediction: evidence - based guidance and consensus. Int J Clin Pract 2010; 64(7): 848-857. Go to original source... Go to PubMed...
    6. De Busc R, Drory R, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease. Recommendations of the Princeton Consensus panel. Am J Cardiol 2000; 86: 175-181. Go to original source... Go to PubMed...
    7. Zámečník L. Erektilní dysfunkce. Postgraduální medicína 2008; 10(4): 383-390.
    8. Kloner R, Padma-Nathan H. Erectile dysfunction in patients with coronary artery disease. Int J Impot Res 2005; 17(3): 209-215. Go to original source... Go to PubMed...
    9. Conti CR, Pepione CJ, Sweenwy M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999; 83: 29-34. Go to original source... Go to PubMed...
    10. Jackson G, Kloner RA, Costigan TM, et al. Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. J Sex Med 2004; 1: 161-167. Go to original source... Go to PubMed...
    11. Stárka L. Hormony se vztahem k sexuálním funkcím. In Weiss P, et al. Sexuologie. Grada Publishing 2010: 69-92.
    12. Linet IO, Neff LL. Intracavernous prostaglandin E1 in erectile dysfunction. Clin Investig 1994; 72: 139-149. Go to original source... Go to PubMed...
    13. ©rámková T, Mechl M. Prostaglandin E 1 Caverject v terapii erektilní dysfunkce. Prakt Lék 1999; 77(6): 296-301.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.